There is No Direct Dose Equivalence Between Memantine ER 7 mg and Donepezil
Memantine and donepezil are not interchangeable medications—they work through completely different mechanisms and cannot be converted or substituted for one another. Memantine ER 7 mg is a titration dose of an NMDA receptor antagonist, while donepezil is a cholinesterase inhibitor; these are distinct drug classes used for dementia treatment 1.
Why This Question Reflects a Fundamental Misunderstanding
- Different mechanisms of action: Donepezil enhances cholinergic neurotransmission by inhibiting acetylcholinesterase, while memantine blocks NMDA receptors to reduce glutamatergic excitotoxicity 2, 3
- Different clinical indications: Donepezil is FDA-approved for mild to severe Alzheimer's disease, while memantine is approved for moderate to severe disease 2, 3
- Complementary, not equivalent: These medications are often used together in combination therapy for moderate to severe Alzheimer's disease, not as alternatives to each other 2, 4, 5
Standard Dosing for Each Medication
Memantine ER Dosing
- Starting dose: 7 mg once daily
- Target dose: 28 mg once daily
- Titration: Increase by 7 mg weekly intervals to reach 28 mg 2, 4
Donepezil Dosing
- Starting dose: 5 mg once daily
- Maintenance dose: 5-10 mg once daily
- Titration: After 4-6 weeks at 5 mg, may increase to 10 mg if tolerated 3
Clinical Context: When to Use Each Medication
For mild to moderate Alzheimer's disease: Start with a cholinesterase inhibitor like donepezil 5 mg daily 1
For moderate to severe Alzheimer's disease: Consider combination therapy with both donepezil (10 mg) and memantine (target 28 mg ER or 20 mg immediate-release) 2, 5, 6
Evidence for Combination Therapy
The FDA label demonstrates that adding memantine to stable donepezil therapy in moderate to severe AD showed statistically significant benefits on cognition (SIB) and function (ADCS-ADL) compared to donepezil alone 2. A fixed-dose combination product containing memantine ER 28 mg plus donepezil 10 mg is available specifically for this purpose 4, 5.
Critical Pitfall to Avoid
Do not attempt to "switch" or "convert" between these medications. If a patient is on memantine ER 7 mg (a titration dose), they should continue titrating up to the target dose of 28 mg. If cholinesterase inhibitor therapy is also indicated, donepezil should be added as a separate medication, not substituted 1.
The evidence consistently shows no convincing superiority of one cholinesterase inhibitor over another, but memantine and cholinesterase inhibitors address different pathophysiologic mechanisms and are not therapeutically equivalent 1.